Phagocytosis of foreign pathogens by cells of the immune system is a vitally important function of innate immunity. The phagocytic response is initiated when ligands on the surface of invading microorganisms come in contact with receptors on the surface of phagocytic cells such as neutrophils, monocytes/macrophages and dendritic cells. The complement receptor CR3 (CD11b/CD18, Mac-1) mediates the phagocytosis of complement protein (C3bi) coated particles. Fc gamma receptors (FcγRs) bind IgG-opsonized particles and provide a mechanism for immune clearance and phagocytosis of IgG-coated particles. We have observed that stimulation of FcγRs modulates CR3-mediated phagocytosis and that FcγRIIA and FcγRI exert opposite (stimulatory and inhibitory) effects. We have also determined that an intact FcγR immunoreceptor tyrosine-based activation motif (ITAM) is required for these effects and have investigated the involvement of downstream effectors. The ability to up-regulate or downregulate CR3 signaling has important implications for therapeutics in disorders involving the host defense system. Both complement receptor 3 (CR3) and Fcγ receptors (FcγRs) play essential roles in the immune response to infection and in inflammatory processes (1) (2) (3) (4) (5) (6) (7) (8) . CR3 (CD11b/CD18, Mac-1), a member of the β2 integrin family, is a heterodimeric receptor composed of a unique α-chain (CD11b) and a β -chain (CD18) common to other β2 integrin family members (1) (2) (3) (4) (5) . CR3 is expressed primarily on monocytes/macrophages and neutrophils in humans and mice and is activated during the initial immune response to infection. C3b, a cleavage product of the CR3 ligand C3, coats invading microbes and is further cleaved to form C3bi, which is recognized and bound by CR3, thus initiating a phagocytic response. FcγRs provide a mechanism for the clearance and phagocytosis of IgG-coated particles (6) (7) (8) (9) (10) . The FcγR response to infection becomes prominent later in host defense when significant IgG production occurs as part of the adaptive immune response. FcγRI and FcγRIIIA consist of an α-chain, which contains the extracellular ligand-binding site, and an associated γ-chain, required for signaling (9) (10) (11) (12) (13) . The γ-chain contains within its cytoplasmic domain the immunoreceptor tyrosinebased activation motif (ITAM), required for many Ig gene-family signaling events (14, 15) . FcγRI and F c γ RIIIA are expressed on human and murine macrophages (9, 10) . FcγRIIA is unique to humans and is expressed on monocytes, macrophages, neutrophils, dendritic cells and platelets (9, 10) . FcγRIIA contains an ITAM sequence within its own cytoplasmic domain (CY) and does not require the γ-chain for signaling (9, 10, 16) . Upon engagement of these FcγRs, the ITAM tyrosines in both the FcR gamma chain and FcγRIIA are rapidly phosphorylated (17) . The tandem SH2 domains of the tyrosine kinase Syk bind the diphosphorylated ITAM, leading to the formation of a signaling complex at the cell membrane. Within the complex, Syk-mediated phosphorylation of several adaptor proteins activates downstream signaling pathways (9, 10, 17) . FcγRIIB, is also expressed on monocytes and macrophages in humans and mice (18) (19) (20) . This receptor, whose ligand-binding extracellular domain is highly homologous to FcγRIIA (18) , contains an immunoreceptor tyrosine-based inhibition motif (ITIM) within its cytoplasmic domain and, in contrast to the other F c γRs, FcγRIIB does not mediate phagocytosis. Rather, stimulation of this receptor results in the downregulation of many FcγR signaling events (20) . There is evidence that signaling through CR3 can affect signaling by FcγRs (21) (22) (23) (24) (25) (26) . Early studies reported that the presence of C3 dramatically reduces the amount of bound IgG required to induce FcγR mediated particle ingestion by monocytes (21, 22) . A later study indicated that blocking CR3 function with anti-CR3 antibodies reduces Fcγ R mediated phagocytosis without impairing binding of FcγR to IgG (23) . There is also evidence that FcγR stimulation can impact the function of CR3. The binding IgG to FcγR in a mouse macrophage cell line (RAW264.7) induces the lateral movement of CR3 to FcγR-containing phagocytic cups, stimulates macrophage adhesion to surfaces coated with CR3 ligands and enhances C3bi binding to CR3 (27) . The exact mechanism(s) by which each receptor affects the function of the interacting receptor, however, remains unclear.
We have now observed that CR3-mediated signaling for phagocytosis is altered when FcγRs and CR3 are co-stimulated and that individual FcγRs play different roles in modulating CR3-mediated phagocytosis. Costimulation of CR3 with FcγRI inhibits CR3-mediated phagocytosis while co-stimulation of CR3 with FcγRIIA enhances CR3-mediated phagocytosis. We show that these effects of FcγRs on CR3 are dependent upon the availability of an intact FcγR ITAM. These observations are important in that they present a potential for selective modulation of the immune response.
EXPERIMENTAL PROCEDURES
Animals, Antibodies and Reagents -Six to ten week old male and female C57/B6 mice were used throughout this study. FcγRIIA transgenic (IIA-TG) mice were kindly provided by Dr. Steven E. McKenzie (Thomas Jefferson University, Philadelphia, PA). γ-KO mice were obtained from Taconic Laboratories (Germantown, NY). Mice expressing FcγRIIA and lacking the γ-chain (IIA-TG x γ-KO) were produced by crossing FcγRIIA-TG mice with γ-chain KO mice. All protocols were performed in accordance with National Institutes of Health guidelines and with the approval of the University of Pennsylvania Animal Use Committee. Anti-human FcγRII mAb IV.3 and IV.3 F(ab') 2 fractions were purified and prepared in our lab using established methods. Anti-mouse FcγRIIB/FcγRIIIA mAb 2.4G2 was obtained from BD Bioscience (San Jose, CA). Anti-Vav antibody (C-14) and anti-actin antibody (I-19) were obtained from Santa Cruz, Biotechnology (Santa Cruz, CA) and antiphosphotyrosine antibody 4G10 from Upstate Laboratories (Charlottesville, VA).
Cell culture and transfection -COS cells were cultured and maintained in Dulbecco's modified Eagle's medium containing glucose (4.5mg/mL), glutamine (2mM), streptomycin (100U/mL), penicillin (100µg/mL) and 10% heat-inactivated fetal bovine serum (FBS). COS cells stably expressing WT FcγRIIA (COS IIA) and COS cells stably expressing a mutant FcγRIIA whose ITAM tyrosines (Y) are replaced with phenylalanine (F) (COSIIA-Y288F Y3 0 4 F) were prepared by calcium phosphate transfection as described previously (28) . FcγRI-γ−γ and FcγRI-γ−γ Y 65F Y76F cDNAs were constructed as described previously (29) and transfected into COSIIA cells using the Fugene 6 transfection reagent (Roche Diagnostics, Mannheim, Germany). In FcγRI-γ−γ Y65FY76F, the γ-chain ITAM tyrosines (Y) (positions 65 and 76) were replaced with phenylalanine (F). THP-1 cells were maintained in RPMI 1640 (Life Technologies, Gaithersburg, MD) containing 10% heat-inactivated FBS, glutamine (2 mM), streptomycin (100U/mL), and penicillin (100µg/mL).
Preparation of murine peritoneal macrophages and human peripheral blood monocytes-Resident macrophages were flushed from the peritoneal cavity of mice using 10ml PBS. After centrifugation and hypotonic lysis to remove red blood cells, the cells were resuspended in RPMI 1640 medium containing 10% fetal calf serum and adhered to tissue culture wells.
Peripheral blood mononuclear cells from healthy individuals were isolated as described previously (29) . Briefly, heparinized blood was centrifuged on FicollHypaque (Lymphocyte Separation Medium; Organon Teknika, Durham, NC), and mononuclear (interface) cells after brief wash were resuspended in complete RPMI 1640 medium containing 10% heat-inactivated Fetal Calf Serum (FCS). Cells were allowed to adhere at 37°C onto flasks precoated with FCS. After 45-60 minutes, non-adherent cells were removed by extensive washing in PBS and were harvested by vigorous agitation. Isolated monocytes were maintained in RPMI 1640 at 37°C in 5% CO 2 .
Flow cytometry Cell samples (~1x10 6 cells) were incubated with the appropriate primary mAb for 30 min at 4°C. The cells were then washed and incubated with fluorescein isothiocyanate-conjugated F(ab') 2 goat antimouse IgG (Tago, Inc., Burlingame, CA) for 30 min at 4°C, washed again and fixed with 2% paraformaldehyde. Isotype control mAbs were used for all reactions, and fluorescence was measured on a Becton Dickinson FACScan (Mansfield, MA). For all samples, 10,000 events were recorded on a logarithmic fluorescence scale.
Preparation of monomeric and heat aggregated human IgG -Monomeric human IgG (mon-IgG) was prepared by ultracentrifugation of human IgG (8mg/800µl IgG) (MP Biomedicals, Cleveland/Akron, OH) at 80,000 rpm for 15min (Beckman TL-100 ultracentrifuge). Heat aggregated human IgG (HA-IgG) was prepared by heating human IgG (10mg/ml) in PBS (without calcium and magnesium) at 62°C for 20 min, followed by centrifugation at 12,000 rpm for 10 min to remove insoluble aggregates (30 o C for 20 min. followed by extensive washing with PBS. The C3bi-opsonized SRBC were resuspended in 500 µl PBS.
Phagocytosis Assays -Cells grown in 6 well plates were overlaid with EC3bi (50µl in 1ml PBS) and incubated at 37°C for 20 min. In co-stimulation studies, HA-IgG (100µg/ml final concentration) was added to cells simultaneous with EC3bi. Unbound EC3bi were removed by washing with PBS. Externally bound EC3bi were removed by a short (40 sec) hypotonic wash. The cells were stained with Wright-Giemsa, and the number of cells with more than one internalized EC3bi was determined in a blinded manner by light microscopy. The contribution of specific FcγRs to CR3-mediated phagocytosis was determined by blocking input from individual FcγRs. Input from FcγRI was blocked by incubating cells with monomeric IgG (10mg/ml, equivalent to the physiological levels of IgG found in the human circulation) for 20 min before addition of HA-IgG and EC3bi. Input from FcγRIIA was blocked by incubating cells with F(ab') 2 mAb IV.3 ( 2 5 µ g/ml) and input from mouse FcγRIIB and F c γ RIIIA was blocked by incubating mouse macrophages with mAb 2.4G2 (25µg/ml). For studies involving the FcγRIIA ITAM, COS cell clones expressing similar levels of WT FcγRIIA or the FcγRIIA ITAM mutant Y288FY304F were used. Approximately 300 cells were counted for each determination. The phagocytic index (PI) is the number of EC3bi internalized per 100 cells.
γ-chain silencing using small interfering RNA (siRNA)-Pooled human γ-chain siRNA was prepared using established protocols provided by Applied Biosytems/Ambien (Austin, TX). The following primers were used to produce cDNA templates: Forward: 5'TAATACGACTCACTATAGGGAAGAT GATTCCAGCAGTGGTC-3'. Reverse: 5'-TAATA CGACTCACTATAGGGCTGTGGTGGTTTCTCATG CTT-3'. Purified human γ-chain siRNA (3µg) was transfected into THP-1 cells (2x10 6 cells) using AMAXA technology (Cell Line Nucleofector Kit V, AMAXA Biosystems, Gaithersburg, MD). After 48 hrs at 37 0 C, cells were evaluated for CR3-mediated phagocytosis in the presence or absence of FcγR costimulation and for efficiency of γ-chain silencing (by RT-PCR and/or Western blotting).
Vav: Immunoprecipitation and Western blotting
Human peripheral monocytes were incubated with reagents at 37°C for 20 min as described for the phagocytosis assays and then lysed directly on culture plates with 500µl of Brij 96 lysis buffer (1% Brij 96, 5mmol/L Hepes-KOH, pH 7.4) containing the protease and phosphatase inhibitors, 5mM EGTA, 3mM Na orthovanadate, 2mM phenylmethylsulfonyl fluoride, and 1µg/L aprotinin and leupeptin (Sigma-Aldrich).
Lysates were immunoprecipitated with 1µg anti-Vav antibody (Santa Cruz Biotechnology) bound to protein G/A plus agarose and washed three times in lysis buffer. Adsorbed proteins were eluted into reducing sample buffer and resolved on NuPAGE 4-12% BisTris Gel (Invitrogen, Carlsbad, CA). Following electrophoretic transfer to nitrocellulose, proteins were immunoblotted with anti-phosphotyrosine (4G10, Upstate Laboratories) or anti-Vav (C-14, Santa Cruz Biotechnology) blotting antibodies followed by goatanti-mouse-IgG-HRP or goat anti-rabbit-IgG-HRP secondary antibody (Santa Cruz Biotechnology). Proteins were visualized by chemiluminescence (ECL Western Blotting Detection Kit, Amersham Biosciences).
RESULTS

Modulation of CR3-mediated phagocytosis by FcγRs: human monocytes -
There is accumulating evidence for interaction(s) between CR3 and FcγRs (21) (22) (23) (24) (25) (26) (27) . To investigate functional consequences and mechanisms involved in the interaction of FcγRs and CR3, we examined the effect of FcγR stimulation on CR3-mediated phagocytosis by human peripheral blood monocytes (PBMs). Although efficient phagocytosis of C3bi-opsonized erythrocytes (EC3bi) by phagocytes often requires a preactivation step (31) (32) (33) , phagocytosis of EC3bi by freshly isolated human PBMs was robust in the absence of any co-stimulating ligand (Fig.1) . Addition of HA-IgG (which binds to and stimulates FcγRs expressed on the surface of PBMs) at the same time as the addition of EC3bi diminished CR3-mediated phagocytosis by 75% (p<0.001), suggesting that co-stimulation of FcγRs with CR3 can modulate CR3 phagocytic function.
Human PBM express three FcγRs; FcγRI, FcγRIIA and FcγRIIB (9, 10) . To examine the role of individual 41% (p<0.01) in CR3-mediated phagocytosis, compared to cells not exposed to HA-IgG and a 5 fold increase over cells in which all FcγRs were stimulated (Fig. 1 ). These observations indicate that blocking FcγRI not only negates the inhibitory effect observed when all FcγRs are stimulated, but suggests that FcγRII stimulation has an enhancing effect on phagocytosis by CR3.
To specifically block the class II FcγRs, we used F(ab') 2 mAb IV.3, which binds and blocks the IgGbinding sites of FcγRIIA and FcγRIIB, leaving only FcγRI available for stimulation by HA-IgG. In PBMs pretreated with F(ab') 2 mAb IV.3, co-stimulation with HA-IgG (for FcγRI) and EC3bi (for CR3) reduced CR3-mediated phagocytosis by 72% compared to cells not exposed to HA-IgG (p<0.002) (Fig. 1) . This observation confirms that FcγRI is responsible for the inhibitory effect observed following co-stimulation of CR3 and FcγRs. Fcγ receptor stimulation does not affect the expression of CR3 on the cell surface of human PBMs nor does CR3 expression change following pre-blocking of the individual FcγRs with antibody or monomeric IgG (not shown). In addition, blocking FcγRI with monomeric IgG does not interfere with the ability of FcγRII to bind HA-IgG (not shown).
To distinguish the contribution of the individual class II Fcγ receptors FcγRIIA and FcγRIIB to CR3-mediated phagocytosis, we utilized peritoneal macrophages from FcγRIIA transgenic mice (IIA-TG). These macrophages have been used as a model system for studies of human macrophage function (34) because they express human FcγRIIA as well as endogenous mouse FcγRI, FcγRIIB and FcγRIIIA. Importantly, mAb 2.4G2 can be used to block input from mouse FcγRIIB and FcγRIIIA (35) , providing a method for distinguishing between the effect of human FcγRIIA and FcγRIIB in these macrophages.
Phagocytosis of EC3bi in IIA-TG macrophages and in WT mouse macrophages is negligible without prepriming or co-stimulation; however, phagocytosis is evident in IIA-TG macrophages co-stimulated with EC3bi and HA-IgG (PI=35) (Fig. 2) . Pretreatment of IIA-TG macrophages with mAb 2.4G2 before costimulation with HA-IgG and EC3bi (Fig. 2) (Fig. 2) . These results parallel our observations in human monocytes;
i.e. specific stimulation of FcγRIIA simultaneous with treatment of CR3 with EC3bi produces an enhancing effect on CR3 mediated phagocytosis whereas inclusion of FcγRI in FcγR stimulation diminishes CR3 mediated phagocytosis. Requirement for the F c γ R γ -chain in Fcγ R I modulation of CR3-mediated phagocytosis -Signaling through FcγRI generally, but not always, requires association with the ITAM-containing FcR γ-chain (9) (10) (11) (36) (37) (38) . We used macrophages from our IIA-TG mice crossed with γ-KO mice (IIA-TG x γ-KO) to examine whether the γ-chain is required for the effect of FcγRI on CR3-mediated phagocytosis. Because in some systems, cell surface expression of FcγRI is severely diminished in the absence of the γ-chain (36), we first examined the cell surface expression of FcγRI on these macrophages. As indicated by fluorescence cytometry, there is somewhat diminished but still robust cell surface expression of FcγRI on these mouse macrophages lacking the γ-chain (Fig. 3A) .
Our studies have demonstrated that when macrophages from IIA-TG mice are treated with mon IgG before addition of HA-IgG and EC3bi, there is an increase in CR3 phagocytosis (Fig. 2) . That blocking the stimulation of FcγRI increases CR3 phagocytosis, indicates that FcγRI exerts a negative effect on CR3 phagocytosis. We hypothesized that if the γ-chain is needed for this negative effect, blocking input from F c γ RI in mouse macrophages lacking γ-chain expression (IIA-TG x γ-KO mice) before addition of HA-IgG and EC3bi will not produce an increase in CR3 phagocytosis. The verification of this thesis is demonstrated in Figure 3B in which the CR3 phagocytic efficiency of IIA-TG cells and IIA-TG x γ-KO cells pretreated with monomeric (mon) IgG are compared. Pretreatment of IIA-TG x γ -K O macrophages with mon IgG did not produce a significant increase in CR3 phagocytosis (p=0.2, Fig.  3B ) whereas, as before, pretreatment of IIA-TG macrophages with mon IgG significantly increased CR3 phagocytosis (p<0.01). Further, within each experiment, the PIs for CR3 in IIA-TG x γ-K O macrophages were consistently higher than those observed for IIA-TG macrophages treated in the same manner. For example, in the representative experiment shown in Figure 3C , the CR3 phagocytic index for non pretreated cells was 137 for IIA-TG x γ-chain KO cells and 35 for IIA-TG cells. We also examined the requirement for the γ-chain in FcγRI inhibition of CR3-mediated phagocytosis in human cells (THP-1) in which γ-chain expression was knocked down using siRNA. THP-1 cells, like human monocytes, express FcγRI, the γ-chain, FcγRIIA and FcγRIIB. Treatment of THP-1 cells with γ-chain siRNA decreased γ-chain protein by >60% (Western blot analysis, Fig. 4A ). In addition, RT-PCR analysis indicated a 90% decrease in γ-chain mRNA (not shown). Analysis by flow cytometry indicated little or no difference between surface expression of FcγRI in cells treated with γ-chain siRNA or control siRNA (not shown).
As expected, in THP1 cells treated with control siRNA, stimulation of cells with EC3bi and HA-IgG inhibited phagocytosis of EC3bi (PI=2 vs non costimulated cells PI=26, p<0.001, Fig. 4B ), reflecting the inhibitory effect of FcγRI/γ. In contrast, phagocytosis of EC3bi was not significantly diminished when cells treated with γ-chain siRNA were co-stimulated with EC3bi and HA-IgG (PI=23 vs non co-stimulated cells PI=25, p=0.2). Together, these studies in mouse macrophages and human monocytic cells provide evidence that signaling through the γ-chain is required for the inhibitory effect of FcγRI on CR3-mediated phagocytosis.
Role of the γ-chain ITAM -Having demonstrated that the γ-chain is required for the FcγRI effect on CR3-mediated phagocytosis, we next examined whether signaling through the γ-chain ITAM is required for modulation of CR3 phagocytosis by FcγRI (Fig. 5) . For these experiments, we used COS cells stably expressing human FcγRIIA (COS IIA) because the baseline for CR3 phagocytosis in COS cells expressing CD11b and CD18 but lacking FcγRIIA is a very low. COS IIA cells were transfected to express CR3 (CD11b and CD18) and RI-γ-γ, a chimera which contains the extracellular domain of Fcγ RI and the transmembrane and cytoplasmic domains of the γ-chain. Other COS IIA cells were transfected to express CR3 (CD11b and CD18) and a mutant RI-γ−γ chimera, in which the γ-chain ITAM tyrosines (Y) were replaced with phenylalanine (F) (Y65F Y 76F). Phosphorylated tyrosines in the ITAM are required for association of the receptor with signaling molecules containing SH2 domains, such as Syk kinase (17, 39) , and the Y 65F Y76F ITAM mutation does not support FcγR signaling functions such as phagocytosis (10, 13, 16) . The transfection of CR3 plus vector alone provides a control for the effect of FcγRIIA on CR3 phagocytosis.
As expected, CR3-mediated phagocytosis for COS IIA cells expressing CR3 plus vector increased following co-stimulation of cells with HA-IgG and EC3bi (PI=22 vs PI=45, p<0.01, Fig.5 ) due to the effect of FcγRIIA, the only FcγR expressed on these cells. The enhancing effect of FcγRIIA was absent in COS IIA cells expressing CR3 plus WT RI-γ−γ ( PI=22 vs PI=18, p=0.2). due to inhibitory input from FcγRI/γ. Similar to cells expressing CR3 plus vector, there was enhancement of CR3-mediated phagocytosis for COS IIA cells expressing CR3 and RI-γ−γ (Y65F Y76F) treated with HA-IgG and EC3bi (PI=26 vs PI=44, p<0.01). This increase in phagocytic efficiency indicates that an intact ITAM is required for the inhibitory effect of the Fcγ RI γ -chain on CR3 phagocytosis and that FcγRI/γ inhibition of CR3 phagocytosis is mediated through its ITAM signaling pathways.
Role of the FcγRIIA ITAM in stimulation of CR3 phagocytosis -Having determined that the γ-chain ITAM is required for inhibition of CR3 phagocytosis by FcγRI, we next examined whether the ITAM of F c γRIIA is essential for enhancement of CR3 phagocytosis. We transfected CD11b and CD18 into COS cell lines stably expressing WT FcγRIIA (COS IIA) or the FcγRIIA-ITAM mutant Y288FY304F (COS IIA-Y288FY304F). The expression level of FcγRIIA was similar in the COS cell clones expressing the WT ITAM or the ITAM mutant.
In COS IIA cells, co-stimulation with HA-IgG increased CR3-mediated phagocytosis over the basal levels observed in cells not exposed to HA-IgG (p<0.01, Fig. 6 ), in accord with our observations in human monocytes and in IIA-TG mouse macrophages (Figs. 1, 2 and 3) . In COS IIA-Y288FY304F cells, CR3 phagocytosis remained near basal levels after costimulation with HA-IgG (p=0.2, Fig. 6 ), an indication that FcγRIIA, like the FcγRI γ-chain requires an intact ITAM to induce modulation of CR3 phagocytosis.
In monocytes and macrophages, Syk kinase is recruited to the tyrosine phosphorylated FcγRIIA ITAM where it undergoes activation and mediates many FcγRIIA signaling functions (39) (40) (41) (42) . COS cells express low levels of Syk kinase (28), and we have previously noted that increasing Syk expression by heterologous transfection enhances FcγR signaling responses in these cells (28, 39) . Overexpression of Syk increased the enhancement of CR3 phagocytosis in COS IIA (WT ITAM) cells (p<0.01) but produced no significant increase in CR3 phagocytosis in COS IIA-Y288FY304F cells (p=0.2) (Fig. 6) . Together, these observations indicate that FcγRIIA enhancement of CR3-mediated phagocytosis is diminished in the absence of ITAM tyrosines.
Effect of FcγR stimulation on Vav phosphorylation
Having demonstrated the requirement for an intact ITAM for modulation of CR3 by both FcγRI/γ and FcγRIIA, we next hypothesized that differential phosphorylation of a downstream effector(s) may determine how these FcγRs affect signaling for CR3 phagocytosis. Guanine exchange factors (GEFs) play important roles in both CR3 and FcγR signaling (43, 44) and it is known that activation of the GEF Vav is required for CR3-mediated phagocytosis (44) . While FcγRs do not require Vav for phagocytic signaling, activation of F c γ Rs does induce tyrosine phosphorylation of Vav (44) . We observed that specific engagement of FcγRII (Fig. 7A, lane 4) , induces a large increase in Vav tyrosine phosphorylation in human monocytes compared to untreated cells and that specific engagement of FcγRI (lane 3) results in a decrease in Vav tyrosine phosphorylation compared to untreated cells. This pattern of Vav phosphorylation was also observed when CR3 and specific FcγRs were costimulated (Fig 7B) . Stimulation of CR3 alone did not produce a discernable change in the basal state of Vav phosphorylation (Fig.7B) . The inhibition and enhancement of Vav phosphorylation by specific FcγRs, evident with and without co-stimulation of CR3, correlates with the pattern of CR3 phagocytosis induced when CR3 and specific FcγRs are costimulated.
DISCUSSION
Our present studies reveal a new aspect in the interaction between CR3 and FcγRs, two important phagocytic receptors involved in the immune response. We have observed that CR3-mediated phagocytosis is modulated when FcγRs and CR3 are co-stimulated ( Figs. 1 and 2) . We have also observed that individual FcγRs play different roles in modulating CR3-mediated phagocytosis. Co-stimulation of CR3 and FcγRI inhibits CR3-mediated phagocytosis, and costimulation of CR3 and FcγRIIA enhances CR3-mediated phagocytosis. As with most FcγRI signaling events, the γ-chain associated with FcγRI is required for the inhibitory effect of FcγRI (Figs. 3B, 3C and 4) and and an intact ITAM is necessary for the effects of both FcγRI and FcγRIIA on CR3 phagocytosis (Figs. 5 and  6 ). Our studies also indicate that FcγRI, generally considered an activating receptor, can exert a negative effect in signaling pathways. Negative effects on signaling pathways by 'activating' ITAM dependent receptors have also been identified in some myeloid cells (15, (45) (46) (47) .
Although both FcγRI and FcγRIIA require intact ITAMs for most signaling events including phagocytosis (9,10,15, Figs. 5,6), they may induce different effects on CR3 signaling for phagocytosis by recruiting/stimulating different downstream effectors and/or by inducing different levels of stimulation (tyrosine phosphorylation) on downstream effectors.
Fc_R ITAM domains couple to downstream signaling pathways through the tyrosine kinase Syk. We and others have demonstrated that Syk is essential for FcγR signaling including phagocytosis (39) (40) (41) 48) . Syk is also essential for CR3-mediated phagocytosis (48) (49) (50) . Our observation that over-expression of Syk intensifies the enhancement of CR3 phagocytosis by FcγRIIA (Fig. 6B) suggests that Syk also participates in the modulation of CR3-mediated phagocytosis by FcγRIIA. For experiments with FcγRI/γ, it was necessary to include expression of Fcγ RIIA because CR3 phagocytosis in the absence of FcγRIIA in COS cells expressing CD11b and CD18 is very low. Participation of Syk in the inhibitory effect of FcγRI could therefore not be evaluated because overexpression of Syk in this system may affect both the FcγRI/γ inhibitory effect and the Fcγ RIIA enhancing effect on CR3 phagocytosis.
Studies in macrophage cell lines and other cell lines have suggested that signaling through both CR3 and F c γR requires activation of guanine nucleotide exchange factors (GEFs), which, in turn, activate members of the Rho GTPase family, implicated in both FcγR and CR3 mediated phagocytosis (43, 44) . Of particular interest is the GEF Vav. Vav is required for complement-mediated phagocytosis, and the activity of Vav, (a substrate of Syk), is modulated by tyrosine phosphorylation (43) . Further, while FcγRs do not require Vav for phagocytic signaling, activation of FcγRs does induce tyrosine phosphorylation of Vav (43, 44) . In human monocytes, specific ligation of F c γ RII induced an increase in Vav tyrosine phosphorylation compared to cells left untreated, and specific ligation of FcγRI resulted in a decrease in Vav tyrosine phosphorylation, paralleling the stimulatory and inhibitory effects of FcγRs on CR3-mediated phagocytosis (Figs. 1 and 7) . The correlation between FcγR induced Vav phosphorylation and the effects of FcγR stimulation on CR3 phagocytosis is intriguing in that it suggests that the tyrosine phosphorylation status of Vav (and/or other downstream effectors), induced by the specific stimulation of FcγRI or FcγRIIA, may contribute to whether CR3 phagocytosis is enhanced or inhibited.
The differential effects of Fcγ Rs on CR3 phagocytosis may be linked with various pathological conditions. In many autoimmune diseases, (e.g. systemic lupus erythematosus, rheumatoid arthritis, glomerulonephritis) C3bi or IgG immune complexes are recognized by inflammatory cells such as macrophages, leading to the release of biologically active products which can lead to tissue damage (51-53). There have been reports that expression of FcγRI is significantly elevated while expression of FcγRII is decreased in monocytes from systemic lupus erythematosus (SLE) patients (54) (55) (56) . In SLE, there are increased levels of circulating immune complexes as well as a reduction in the clearance of apoptotic bodies (56, 57) . Increased expression of FcγRI may contribute to defective CR3-mediated clearing of apoptotic cells in lupus patients. Similarly, a decrease in FcγRII expression may minimize an activating contribution to the CR3 response by FcγR I I A .
Together, these conditions may interfere with the ability of SLE patients to clear circulating immune complexes and apoptotic bodies that arise from the production of autoantibodies, thus contributing to the manifestations of the disease.
That individual FcγRs play different roles in modulating CR3-mediated phagocytosis has important implications for therapeutics and we anticipate that further investigations of the interactions of CR3 and F c γ Rs will help identify new approaches for modulating the early stages of the immune response. (4) blocking input from FcγRI with monomeric (mon) IgG before co-stimulation with HA-IgG. Phagocytosis is analysed as the phagocytic index (PI) the number of red blood cells ingested per 100 cells. The figure presents the % change of PI from untreated (basal) levels for each treatment group. In three independent experiments, basal levels of phagocytosis were 158, 118 and 121 (average 132+/-22). Although the PIs varied, in each experiment the percent change from basal levels was similar for each condition. Human Monocytes
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